Document is current
Any future updates will be listed below
-
Authors
Ring, Alistair
Karuturi, Meghan
Smyth, Emily Nash
Lokhandwala, Tasneem http://orcid.org/0000-0002-1983-9557
Sheffield, Kristin M.
Willey, Joanne
Lunacsek, Orsolya
Sapunar, Francisco
Cui, Zhanglin Lin
Coutinho, Anna D.
Rybowski, Sarah
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Accepted: 16 August 2023
First Online: 29 September 2023
Declarations
:
: This work was funded by Eli Lilly and Company. The sponsor participated in the collection (co-creation of data collection form), analysis, and interpretation of the data and decision to submit the article for publication. All authors vouch for the accuracy of the manuscript and data contained within.
: Xcenda LLC is a consulting firm that received fees for the conduct of this work from Eli Lilly and Company. A.R. and M.K. have received honoraria for educational activities and advisory boards from Eli Lilly. E.S., K.S., F.S., Z.C., and S.R. are employees of Eli Lilly and company and hold company stock. T.L. is an employee of Xcenda, LLC and may own AmerisourceBergen stock. J.W, O.L., and A.C. were employees of Xcenda, LLC at the time of conduct of the study and may own AmerisourceBergen stock.
: The study was approved with a waiver of consent and a full waiver of Health Insurance Portability and Accountability Act authorization by the Advarra Institutional Review Board.
: Not applicable.
: Not applicable.
: The dataset is not available for publication as the research data are confidential. Please reach out to the corresponding author with any questions.
: The SAS code is not available for publication. Please reach out to the corresponding author with any questions.
: Conception and design: all authors; data collection: T.L., J.W., O.L., AC; analysis and interpretation of the data: all authors; manuscript writing and editing: all authors; approval of the final article: all authors.
